Evidence map›Paper›PMID 36333334›Full record

ArticleScientific reports2022

The use of biological amniotic membranes in the treatment of recurrent macular holes.

Gang Qiao, Lijun Xie, Qiangxing Zou, Chunmei He, Xiaojuan Zhang, Ziyan Tang, Shuai Zou, Kui Cao

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Optimal approaches for managing recurrent macular holes: a comprehensive systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Pooled it
  2. Article
  3. Article
  4. Descemet's membrane transplantation for the treatment of recurrent high myopic macular hole associated with retinal detachment : Descemet's membrane for myopic macular hole.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  5. Biological ultrathin amniotic membrane flap to close refractory macular holes associated with high myopia.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gang QiaoMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Lijun XieMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China. shallyjune@163.com.
Qiangxing ZouMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Chunmei HeMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Xiaojuan ZhangMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Ziyan TangMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Shuai ZouMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.
Kui CaoMianyang Wanjiang Eye Hospital, Mianyang, 621000, Sichuan, China.

Funding

Sichuan Medical Research Fund S20018
6 · The paper itself

Abstract

To evaluate the clinical therapeutic effects of a technique in which biological amniotic membranes (bAMs) are used in the treatment of patients with recurrent macular holes. In this prospective nonrandomized case series study, 23 eyes of 23 patients with recurrent macular holes who had already undergone surgery with pars plana vitrectomy with internal limiting membrane peeling were evaluated. In the surgery, a bAM was used to cover the macular area, and C

Indexed as

Epiretinal MembraneRetinal PerforationsAmnionBasement MembraneHumansProspective StudiesRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeVitrectomy

Identifiers

PMID36333334
PMCPMC9636383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.